{"transactions":[{"id":2413090,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-03T22:29:44.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control."}],"balance_after":32000,"source":{"system":"sec-edgar","filing":"0001562180-22-001072","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218022001072/primarydocument.xml","form_type":"4"}},{"id":2502349,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-11-19T21:06:34.000Z","date":"2021-11-18","kind":"exercise","acquired":false,"shares":30,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.88,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001562180-21-007180","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021007180/primarydocument.xml","form_type":"4"}},{"id":2502348,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-11-19T21:06:34.000Z","date":"2021-11-18","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.93,"expiration_date":"2028-05-23","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001562180-21-007180","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021007180/primarydocument.xml","form_type":"4"}},{"id":2502347,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T21:06:34.000Z","date":"2021-11-18","kind":"sale","acquired":false,"shares":30,"price":18.0323,"value":540.969,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale prices ranged from $18.03 to $19.03."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001562180-21-007180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021007180/primarydocument.xml","form_type":"4"}},{"id":2502346,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T21:06:34.000Z","date":"2021-11-18","kind":"exercise","acquired":true,"shares":30,"price":7.88,"value":236.4,"ownership":{"direct":true},"balance_after":16030,"source":{"system":"sec-edgar","filing":"0001562180-21-007180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021007180/primarydocument.xml","form_type":"4"}},{"id":2502345,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T21:06:34.000Z","date":"2021-11-18","kind":"sale","acquired":false,"shares":14000,"price":18.0323,"value":252452.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale prices ranged from $18.03 to $19.03."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001562180-21-007180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021007180/primarydocument.xml","form_type":"4"}},{"id":2502344,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T21:06:34.000Z","date":"2021-11-18","kind":"exercise","acquired":true,"shares":14000,"price":8.93,"value":125020.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001562180-21-007180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021007180/primarydocument.xml","form_type":"4"}},{"id":2594572,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-08-20T20:32:17.000Z","date":"2021-08-18","kind":"exercise","acquired":false,"shares":15635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.88,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001562180-21-005491","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021005491/primarydocument.xml","form_type":"4"}},{"id":2594571,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T20:32:17.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":15635,"price":15.7549,"value":246327.8615,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.  Following the sale reported in this Form 4, the Reporting Person has a total of 77,682 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale prices ranged from $15.58 to $15.94."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001562180-21-005491","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021005491/primarydocument.xml","form_type":"4"}},{"id":2594570,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T20:32:17.000Z","date":"2021-08-18","kind":"exercise","acquired":true,"shares":15635,"price":7.88,"value":123203.8,"ownership":{"direct":true},"balance_after":31635,"source":{"system":"sec-edgar","filing":"0001562180-21-005491","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021005491/primarydocument.xml","form_type":"4"}},{"id":2702623,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-05-20T20:46:20.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":11926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.2,"expiration_date":"2025-08-18","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001562180-21-003670","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021003670/primarydocument.xml","form_type":"4"}},{"id":2702622,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-05-20T20:46:20.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":1683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.88,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001562180-21-003670","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021003670/primarydocument.xml","form_type":"4"}},{"id":2702621,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T20:46:20.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":1683,"price":18.6482,"value":31384.9206,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.  Following the sale reported in this Form 4, the Reporting Person has a total of 93,317 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001562180-21-003670","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021003670/primarydocument.xml","form_type":"4"}},{"id":2702620,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T20:46:20.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":11926,"price":18.6482,"value":222398.4332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.  Following the sale reported in this Form 4, the Reporting Person has a total of 93,317 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested."}],"balance_after":17683,"source":{"system":"sec-edgar","filing":"0001562180-21-003670","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021003670/primarydocument.xml","form_type":"4"}},{"id":2702619,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T20:46:20.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":1683,"price":7.88,"value":13262.04,"ownership":{"direct":true},"balance_after":29609,"source":{"system":"sec-edgar","filing":"0001562180-21-003670","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021003670/primarydocument.xml","form_type":"4"}},{"id":2702618,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T20:46:20.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":11926,"price":7.2,"value":85867.2,"ownership":{"direct":true},"balance_after":27926,"source":{"system":"sec-edgar","filing":"0001562180-21-003670","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021003670/primarydocument.xml","form_type":"4"}},{"id":2811867,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-03-03T21:16:46.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":10167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.35,"expiration_date":"2024-12-18","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001562180-21-001909","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021001909/primarydocument.xml","form_type":"4"}},{"id":2811866,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2021-03-03T21:16:46.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":74,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.2,"expiration_date":"2025-08-18","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001562180-21-001909","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021001909/primarydocument.xml","form_type":"4"}},{"id":2811865,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T21:16:46.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":74,"price":24.3122,"value":1799.1028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 106,926 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale prices ranged from $23.84 to $25.15."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001562180-21-001909","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021001909/primarydocument.xml","form_type":"4"}},{"id":2811864,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T21:16:46.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":10167,"price":24.3122,"value":247182.1374,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sale reported in this Form 4, the Reporting Person has a total of 106,926 options to purchase shares of common stock that are vested and immediately exercisable and a total of 0 options to purchase shares of common stock that have not yet vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale prices ranged from $23.84 to $25.15."}],"balance_after":16074,"source":{"system":"sec-edgar","filing":"0001562180-21-001909","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021001909/primarydocument.xml","form_type":"4"}},{"id":2811863,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T21:16:46.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":74,"price":7.2,"value":532.8,"ownership":{"direct":true},"balance_after":26241,"source":{"system":"sec-edgar","filing":"0001562180-21-001909","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021001909/primarydocument.xml","form_type":"4"}},{"id":2811862,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T21:16:46.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":10167,"price":6.35,"value":64560.45,"ownership":{"direct":true},"balance_after":26167,"source":{"system":"sec-edgar","filing":"0001562180-21-001909","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021001909/primarydocument.xml","form_type":"4"}},{"id":2876348,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-05T21:18:12.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units that vests one year from the date of grant.  The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001562180-21-000925","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218021000925/primarydocument.xml","form_type":"4"}},{"id":3270001,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T21:35:56.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24000,"derivative":{"exercise_price":9.47,"exercise_date":"2021-02-12","expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001562180-20-001233","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218020001233/primarydocument.xml","form_type":"4"}},{"id":3492371,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-12T13:00:29.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24000,"derivative":{"exercise_price":7.88,"exercise_date":"2020-06-10","expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001562180-19-003487","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218019003487/primarydocument.xml","form_type":"4"}},{"id":3916740,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-25T13:00:17.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14000,"derivative":{"exercise_price":8.93,"exercise_date":"2019-05-23","expiration_date":"2028-05-23","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001562180-18-002684","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218018002684/primarydocument.xml","form_type":"4"}},{"id":4065670,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T21:00:51.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option shall vest monthly over a three-year period."}],"balance_after":10000,"derivative":{"exercise_price":9.63,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-18-000719","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218018000719/primarydocument.xml","form_type":"4"}},{"id":4311403,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-19T15:26:37.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option shall vest monthly over a three-year period."}],"balance_after":5000,"derivative":{"exercise_price":13.58,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-17-002005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218017002005/primarydocument.xml","form_type":"4"}},{"id":4311402,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-19T15:26:37.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":13.58,"exercise_date":"2018-05-17","expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-17-002005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218017002005/primarydocument.xml","form_type":"4"}},{"id":4569126,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":130798,"kind":"person","name":"Egros Fabrice","position":1,"cik":"0001597085","reported_name":"Egros Fabrice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-02T21:25:10.000Z","date":"2016-10-31","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date."}],"balance_after":8000,"derivative":{"exercise_price":11.81,"expiration_date":"2026-10-31","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001562180-16-003352","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218016003352/primarydocument.xml","form_type":"4"}}]}